Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Positive Results from an Exploratory Phase I/II Study with UC1010 in PMDD
Tuesday, September 23, 2014
Results show a significant improvement of symptoms in patients treated with UC1010.

Jumpstart Joins Bionow
Tuesday, September 23, 2014
Membership will aim to help life science businesses in Northern England.

Horizon Reports a Strong First Half
Tuesday, September 23, 2014
Interim results for the six months ended 30 June 2014 position the company for continued growth.

Adaptimmune Named as One of “Fierce 15” Biotech Companies of 2014
Tuesday, September 23, 2014
Company has created T-cell receptors which are deployed to target NY-ESO-1.

Clinical Trial to Assess Efficacy and Safety of LMTX™ in Alzheimer’s Disease
Monday, September 22, 2014
TauRx Therapeutics Achieves Enrolment Target for Second Phase III Clinical Trial of LMTX™ in Alzheimer’s Disease.

Recipharm Secures Financing for Continued Growth
Saturday, September 20, 2014
New SEK 1 500 million loan facility with Scandinavia; DNB, Handelsbanken and Swedbank banks.

BioLineRx Presents Positive Preclinical Results in Treatment for AML Patients
Saturday, September 20, 2014
Results in this additional indication for BL-8040 presented at Society of Hematologic Oncology Annual Meeting.

Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Friday, September 19, 2014
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.

Avraham Pharmaceuticals Raises $4.5 Million
Friday, September 19, 2014
The capital is intended for the on-going Phase 2b clinical trial of ladostigil, a novel molecule for treatment of mild cognitive impairment.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3157
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv